Melanoma Stage Ii clinical trials

Explore recruiting melanoma stage ii clinical trials.

Recruiting melanoma stage ii studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Melanoma Stage Ii trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Pharmacokinetics (PK) study to compare GME751 (proposed pembrolizumab biosimilar) and United States (US)-licensed and European Union (EU)-approved Keytruda®in participants with stage Ⅱ and Ⅲ skin cancer requiring adjuvant treatment (therapy applied after initial treatment of cancer to suppress the regrowth of tumor) with pembrolizumab.

Romania, Germany, Italy, Lithuania, France, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

An open-label, multi-center, single arm, rollover study of GME751 (proposed pembrolizumab biosimilar) in participants who are eligible for continued pembrolizumab treatment after participation in CGME751A12101 or CGME751A12301 studies.

Romania, Lithuania, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Melanoma Stage Ii trials by city

Melanoma Stage Ii in Toronto Melanoma Stage Ii in Vancouver Melanoma Stage Ii in Montreal Melanoma Stage Ii in Calgary Melanoma Stage Ii in Edmonton Melanoma Stage Ii in Ottawa Melanoma Stage Ii in Winnipeg Melanoma Stage Ii in Quebec City Melanoma Stage Ii in Hamilton Melanoma Stage Ii in Kitchener Melanoma Stage Ii in London Melanoma Stage Ii in Halifax Melanoma Stage Ii in New York Melanoma Stage Ii in Los Angeles Melanoma Stage Ii in Chicago Melanoma Stage Ii in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease